Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-06-01 Sale | 2026-06-03 4:25 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | PYOTT DAVID E I Director | 3,830 | $299.18 | $1,145,853 | 29,482 (Indirect Direct) | View |
| 2026-04-02 Sale | 2026-04-07 4:21 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | McLaughlin Melissa Chief Human Resources Officer | 3,910 | $325.92 | $1,274,343 | 9,443 (Direct) | View |
| 2026-03-04 Sale | 2026-03-06 4:13 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal EVP Chief R&D | 4,713 | $323.53 | $1,524,796 | 19,374 (Indirect Direct) | View |
| 2026-03-04 Sale | 2026-03-06 4:13 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 2,933 | $323.08 | $947,581 | 96,102 (Indirect Direct) | View |
| 2026-03-04 Sale | 2026-03-06 4:12 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 2,468 | $323.08 | $797,351 | 61,862 (Indirect Direct) | View |
| 2026-03-04 Sale | 2026-03-06 4:12 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 2,309 | $323.08 | $745,984 | 34,297 (Direct) | View |
| 2026-03-04 Sale | 2026-03-06 4:11 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | 1,291 | $323.54 | $417,685 | 21,106 (Indirect Direct) | View |
| 2026-03-02 Sale | 2026-03-04 7:31 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 2,206 | $327.65 | $722,801 | 74,810 (Indirect Direct) | View |
| 2026-03-02 Sale | 2026-03-04 7:31 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal EVP Chief R&D | 3,492 | $323.63 | $1,130,131 | 34,567 (Indirect Direct) | View |
| 2026-03-02 Sale | 2026-03-04 7:30 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | 3,250 | $323.62 | $1,051,773 | 30,502 (Indirect Direct) | View |
| 2026-03-02 Sale | 2026-03-04 7:30 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 1,598 | $327.65 | $523,584 | 47,086 (Direct) | View |
| 2026-03-02 Sale | 2026-03-04 7:29 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 6,799 | $327.65 | $2,227,698 | 240,206 (Indirect Direct) | View |
| 2026-02-27 Sale | 2026-03-02 4:08 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal EVP Chief R&D | 4,627 | $331.34 | $1,533,100 | 22,810 (Indirect Direct) | View |
| 2026-02-13 Sale | 2026-02-17 7:28 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal EVP Chief R&D | 2,242 | $310.08 | $695,201 | 25,529 (Indirect Direct) | View |
| 2026-02-13 Sale | 2026-02-17 7:27 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 6,958 | $310.08 | $2,157,542 | 86,069 (Indirect Direct) | View |
| 2026-02-13 Sale | 2026-02-17 7:27 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 1,959 | $310.08 | $607,448 | 31,769 (Direct) | View |
| 2026-02-13 Sale | 2026-02-17 7:26 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | 4,000 | $321.24 | $1,284,980 | 21,801 (Indirect Direct) | View |
| 2026-02-13 Sale | 2026-02-17 7:26 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 2,242 | $310.08 | $695,201 | 59,859 (Indirect Direct) | View |
| 2026-01-12 Sale | 2026-01-14 4:23 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal EVP Chief R&D | 1,510 | $362.87 | $547,929 | 23,192 (Indirect Direct) | View |
| 2026-01-12 Sale | 2026-01-14 4:23 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 9,577 | $362.86 | $3,475,157 | 78,818 (Indirect Direct) | View |
| 2026-01-12 Sale | 2026-01-14 4:22 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 2,780 | $362.87 | $1,008,766 | 57,522 (Indirect Direct) | View |
| 2026-01-12 Sale | 2026-01-14 4:22 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 1,510 | $362.87 | $547,927 | 29,728 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-06-01 Exercise | 2026-06-03 4:25 pm | 2017-06-03 2026-06-03 | ALNYLAM PHARMACEUTICALS INC. | ALNY | PYOTT DAVID E I Director | 3,830 | $0 | 29,482 (Direct) | View |
| 2026-06-01 Option Award | 2026-06-03 4:23 pm | 2027-06-01 2036-06-01 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Cravatt Benjamin Director | 4,393 | $0 | 4,393 (Direct) | View |
| 2026-05-20 Option Award | 2026-05-22 4:20 pm | 2027-05-20 2036-05-20 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Sigal Charles Elliott Director | 2,112 | $0 | 4,887 (Direct) | View |
| 2026-05-20 Option Award | 2026-05-22 4:18 pm | 2027-05-20 2036-05-20 | ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director | 2,640 | $0 | 25,851 (Direct) | View |
| 2026-05-20 Option Award | 2026-05-22 4:16 pm | 2027-05-20 2036-05-20 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Reitan Colleen F Director | 2,112 | $0 | 2,887 (Direct) | View |
| 2026-05-20 Option Award | 2026-05-22 4:14 pm | 2027-05-20 2036-05-20 | ALNYLAM PHARMACEUTICALS INC. | ALNY | PYOTT DAVID E I Director | 2,112 | $0 | 30,923 (Direct) | View |
| 2026-05-20 Option Award | 2026-05-22 4:12 pm | 2027-05-20 2036-05-20 | ALNYLAM PHARMACEUTICALS INC. | ALNY | KELLOGG PETER N Director | 2,112 | $0 | 2,887 (Direct) | View |
| 2026-05-20 Option Award | 2026-05-22 4:11 pm | 2027-05-20 2036-05-20 | ALNYLAM PHARMACEUTICALS INC. | ALNY | HAMBURG MARGARET A Director | 2,112 | $0 | 3,023 (Direct) | View |
| 2026-05-20 Option Award | 2026-05-22 4:08 pm | 2027-05-20 2036-05-20 | ALNYLAM PHARMACEUTICALS INC. | ALNY | BRANDICOURT OLIVIER Director | 2,112 | $0 | 2,887 (Direct) | View |
| 2026-05-20 Option Award | 2026-05-22 4:06 pm | 2027-05-20 2036-05-20 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Ausiello Dennis A Director | 2,112 | $0 | 6,523 (Direct) | View |
| 2026-05-20 Option Award | 2026-05-22 4:04 pm | 2027-05-20 2036-05-20 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Arbuckle Stuart A Director | 2,112 | $0 | 2,112 (Direct) | View |
| 2026-05-13 Exercise | 2026-05-14 4:17 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director | 11,250 | $70.2 | 23,211 (Direct) | View |
| 2026-05-13 Exercise | 2026-05-14 4:17 pm | 2017-06-03 2026-06-03 | ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director | 11,250 | $0 | 23,211 (Direct) | View |
Ownership | 2026-04-07 4:16 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | McLaughlin Melissa Chief Human Resources Officer | 0 | $0 | 16,920 (Direct) | View |
| 2026-03-02 Option Award | 2026-03-04 7:31 pm | N/A 2036-03-02 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 15,249 | $0 | 74,810 (Direct) | View |
| 2026-03-02 Option Award | 2026-03-04 7:31 pm | N/A 2036-03-02 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal EVP Chief R&D | 15,249 | $0 | 34,567 (Direct) | View |
| 2026-03-02 Option Award | 2026-03-04 7:30 pm | N/A 2036-03-02 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | 11,793 | $0 | 30,502 (Direct) | View |
| 2026-03-02 Option Award | 2026-03-04 7:30 pm | N/A 2036-03-02 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 15,249 | $0 | 47,086 (Direct) | View |
| 2026-03-02 Option Award | 2026-03-04 7:29 pm | N/A 2036-03-02 | ALNYLAM PHARMACEUTICALS INC. | ALNY | SUPRAN BRYAN EVP, CLO and Secretary | 4,920 | $0 | 17,946 (Direct) | View |
| 2026-03-02 Option Award | 2026-03-04 7:29 pm | N/A 2036-03-02 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 155,015 | $0 | 240,206 (Direct) | View |
| 2026-02-27 Exercise | 2026-03-02 4:10 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 5,921 | $0 | 91,990 (Direct) | View |
| 2026-02-27 Exercise | 2026-03-02 4:09 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 1,908 | $0 | 61,767 (Direct) | View |
| 2026-02-27 Exercise | 2026-03-02 4:09 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 1,666 | $0 | 33,435 (Direct) | View |
| 2026-02-27 Exercise | 2026-03-02 4:08 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal EVP Chief R&D | 1,908 | $0 | 22,810 (Direct) | View |
| 2026-02-23 Option Award | 2026-02-25 4:17 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | 158 | $0 | 21,959 (Direct) | View |
| 2026-02-12 Option Award | 2026-02-17 7:28 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal EVP Chief R&D | 4,579 | $0 | 25,529 (Direct) | View |
| 2026-02-12 Option Award | 2026-02-17 7:27 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 14,209 | $0 | 86,069 (Direct) | View |
| 2026-02-12 Option Award | 2026-02-17 7:27 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 4,000 | $0 | 31,769 (Direct) | View |
| 2026-02-12 Option Award | 2026-02-17 7:26 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | 4,000 | $0 | 21,801 (Direct) | View |
| 2026-02-12 Option Award | 2026-02-17 7:26 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 4,579 | $0 | 59,859 (Direct) | View |
| 2026-01-11 Option Award | 2026-01-14 4:23 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal EVP Chief R&D | 3,800 | $0 | 23,192 (Direct) | View |
| 2026-01-11 Option Award | 2026-01-14 4:23 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 19,003 | $0 | 78,818 (Direct) | View |
| 2026-01-11 Option Award | 2026-01-14 4:22 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 6,193 | $0 | 57,522 (Direct) | View |
| 2026-01-11 Option Award | 2026-01-14 4:22 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 3,800 | $0 | 29,728 (Direct) | View |